Form4insider filings, from the source

SEC Form 4 · accession 0001535610-18-000069

Rosetta Genomics Ltd. · ROSG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Mar 14, 2018
Accepted (ET)
Mar 16, 2018 · 10:28 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001362959

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 14, 2018P800$0.4199A751,349ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 14, 2018P4,271$0.42A755,620ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 14, 2018P200$0.42A755,820ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 14, 2018P17,900$0.424A773,720ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 14, 2018P50,020$0.4201A823,740ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 15, 2018P15,025$0.4205A838,765ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 15, 2018P34$0.42A838,799ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 15, 2018P3,566$0.42A842,365ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 15, 2018P13,545$0.42A855,910ISee Footnotes
ADR Shares (each one equal to 2 ordinary shares)F1,F2Mar 15, 2018P14,400$0.4205A870,310ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses